Life Science

Life Science

DIANA Biotechnologies is developing a very precise and sensitive method that enables the determination of the quantity of enzymes and their proteins in solutions. Thanks to this, it is possible to diagnose various infectious diseases at a very early stage.

Life Science

Sampling Human is developing diagnostic methods for serious diseases. With the help of synthetic biology, it genetically converts microorganisms, for example yeast cells, which are then able to discover and analyse cellular changes showing the onset of an autoimmune or tumorous disease.

Life Science

Scase works on the development of portable diagnostic equipment usable in telemedicine. The developed equipment combines measurement of a patient's vital functions through several sensors with remote communication between a doctor and patient.

Life Science

Powerful Medical digitises and evaluates ECG recordings. The PMcardio device uses machine learning and artificial intelligence to compare ECG recordings with millions of other cases and based on this it can help determine the diagnosis and recommend treatment. It therefore helps rapidly and precisely recognise cardiovascular disease.

Life Science

Nanuntio focuses on research, development, registration and production of nano-fibre materials and bio-materials for use in medicine and cosmetics. The main aim is the production of non-stick wound dressings for professional uses, that, thanks to their properties, can be enhanced by additional active substances.

Life Science

Q2 Pharma focuses on research into medicines against "superbacteria" resistant to available antibiotics. Whereas antibiotics kill bacteria, the newly-developed F19 substance, as an anti-viral, prevents the release of bacterial toxin, enabling the immune system to more effectively perform its work and deal with an infection.

Life Science

Scipher Medicine focuses on the development of a method that will be able, based on a simple test, to ascertain whether and how patients' molecular profiles will respond to certain drugs. This method can, thanks to the link-up between blood diagnostics and bio-information, predict the effectiveness of treatment for specific patients with a high degree of precision.

Life Science

Ginkgo Bioworks is involved in the genetic modification of organisms and research into the development of enzymes that are the main catalysers of the chemical reactions and that determine their nature and speed. After finding the correct enzymes and combining them, Ginkgo genetically modifies yeast cells, which can produce almost anything – from the aroma of roses to peach oil. The technology can be used in the food, pharmaceuticals and cosmetics industries.

Life Science

Finch Therapeutics researches wide-spectrum microorganisms for the purpose of treating ordinary or unspecified bowel inflammations (IBD). Intestinal diseases are some of the most widespread and 60% of patients treated with antibiotics are resistant. Compared to this, treatment with wide-spectrum microorganisms has an 88% success rate. Finch Therapeutics is developing a new group of perorally-administered biological drugs with the potential to renew the functionality of the intestinal microbiome and deal with states caused by its disturbance.

Life Science

Pendulum is involved in the development of new treatment methods focused on the human microbiome that will improve the lives of patients suffering from various diseases. Its products using natural bacterial phylum help renew the balance of the microbiome, which improves a person's health. Health is related to a comprehensive ecosystem of microorganisms that comprise a microbiome, and the resolution of an imbalance in the microbiome could change the quality of a person's life.

Life Science

Eagle Genomics applies network science to biology. It reveals the influence of the microbiome on people, animals and the environment to ensure a sustainable future. Eagle Genomics provides basic tools for analysis, research and use of comprehensive data about the microbiome.

Life Science

Groundwork BioAg® produces mycorrhizal inoculants for commercial agriculture. They positively influence mycorrhiza, the symbiotic coexistence of fungi and the roots of land plants (Embryophyte). Its environmentally-friendly products improve plant yields, increase their resistance to external influences and reduce the demands for fertilisers.

Life Science

Hexagon Bio is a bio-pharmaceutical company that develops targeted therapy using small molecules. It combines data science, genomics, synthetic biology, chemistry and automation to discover effective, evolution-perfected small molecules and their related aims directly from DNA sequences. It draws inspiration from fungi genomes for a new generation of targeted therapies for hitherto difficult to treat illnesses.

Life Science

IPSX is a platform used for looking for interesting business opportunities in commercial properties.

Life Science

Lavanda is an award-winning new-generation SaaS platform that supports the convergence of residential properties, hotel and restaurant services and travelling.